MeSH term
Frequency | Condition_Probility | Heterozygote | 2 | 0.0 |
Humans | 43 | 0.0 |
Mutation | 12 | 0.0 |
Nephrotic Syndrome/*genetics | 2 | 15.0 |
Proteins/*genetics | 10 | 0.0 |
Proteinuria/*genetics | 2 | 28.0 |
Alleles | 3 | 0.0 |
Female | 11 | 0.0 |
Finland | 6 | 2.0 |
Genotype | 7 | 0.0 |
Pregnancy | 3 | 0.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
Animals | 18 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Mice | 12 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Base Sequence | 6 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Child, Preschool | 3 | 0.0 |
Infant | 5 | 0.0 |
Proteinuria/etiology | 3 | 10.0 |
Gene Targeting | 2 | 0.0 |
Proteins/genetics | 5 | 0.0 |
Adult | 6 | 0.0 |
Child | 6 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Glomerulosclerosis, Focal/genetics | 3 | 60.0 |
Male | 13 | 0.0 |
Phenotype | 3 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Biological Transport | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Gene Expression | 5 | 0.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Microscopy, Immunoelectron | 3 | 0.0 |
Nephrotic Syndrome/congenital/genetics | 3 | 75.0 |
Cell Membrane/metabolism | 3 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
*Protein Biosynthesis | 4 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Kidney/cytology | 3 | 1.0 |
Sensitivity and Specificity | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Exons/genetics | 2 | 0.0 |
Animals, Newborn | 2 | 0.0 |
Blotting, Western | 5 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Microscopy, Electron | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Genes, Recessive | 4 | 0.0 |
Infant, Newborn | 3 | 0.0 |
*Mutation, Missense | 3 | 0.0 |
Nephrotic Syndrome/congenital/*genetics | 3 | 100.0 |
Proteins/analysis/*genetics | 2 | 6.0 |
Phosphorylation | 3 | 0.0 |
Tyrosine/metabolism | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Rats | 2 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Glomerular Filtration Rate | 2 | 1.0 |
Nephrotic Syndrome/genetics | 2 | 33.0 |
Cosmids | 2 | 0.0 |
Finland/epidemiology | 2 | 1.0 |
Incidence | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Aged | 4 | 0.0 |
Gene Frequency | 2 | 0.0 |
Middle Aged | 5 | 0.0 |
Adolescent | 3 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Mutant Strains | 3 | 0.0 |
Membrane Proteins/*genetics/metabolism | 2 | 1.0 |
Transfection | 2 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Membrane Proteins/genetics | 3 | 0.0 |
